[go: up one dir, main page]

DK1001760T3 - Præparat til behandling af sindslidelser hos sunde individer - Google Patents

Præparat til behandling af sindslidelser hos sunde individer

Info

Publication number
DK1001760T3
DK1001760T3 DK98929625T DK98929625T DK1001760T3 DK 1001760 T3 DK1001760 T3 DK 1001760T3 DK 98929625 T DK98929625 T DK 98929625T DK 98929625 T DK98929625 T DK 98929625T DK 1001760 T3 DK1001760 T3 DK 1001760T3
Authority
DK
Denmark
Prior art keywords
preparation
treatment
healthy individuals
mental disorders
carnitine
Prior art date
Application number
DK98929625T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1001760T3 publication Critical patent/DK1001760T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98929625T 1997-06-18 1998-06-12 Præparat til behandling af sindslidelser hos sunde individer DK1001760T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani
PCT/IT1998/000157 WO1998057629A1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals

Publications (1)

Publication Number Publication Date
DK1001760T3 true DK1001760T3 (da) 2005-05-23

Family

ID=11405131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98929625T DK1001760T3 (da) 1997-06-18 1998-06-12 Præparat til behandling af sindslidelser hos sunde individer

Country Status (13)

Country Link
US (1) US6335021B1 (da)
EP (1) EP1001760B1 (da)
JP (1) JP2002505681A (da)
KR (1) KR20010013887A (da)
AT (1) ATE288265T1 (da)
AU (1) AU7930498A (da)
CA (1) CA2294589A1 (da)
DE (1) DE69828881T2 (da)
DK (1) DK1001760T3 (da)
ES (1) ES2236910T3 (da)
IT (1) IT1291930B1 (da)
PT (1) PT1001760E (da)
WO (1) WO1998057629A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
WO2002070037A2 (en) * 2001-03-04 2002-09-12 Sterling Medivations, Inc. Infusion hub assembly and fluid line disconnect system
HUP0400007A2 (hu) * 2001-05-29 2004-04-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Alkanoil-L-karnitin alkalmazása anhedónia kezelésére szolgáló gyógyászati készítmény előállítására
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US20040071681A1 (en) * 2002-10-10 2004-04-15 Lydia Muller Method and composition for reducing cravings for a craved substance
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
ATE437884T1 (de) * 2003-05-29 2009-08-15 Jay W Pettegrew Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
JP2006137746A (ja) * 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
WO2007011839A2 (en) * 2005-07-15 2007-01-25 Agilis Systems, Inc. Mobile resource location-based customer contact systems and methods
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US8068991B2 (en) * 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
EP2582368B1 (en) 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
MX2022012693A (es) 2020-05-15 2022-11-07 Alfasigma Spa Composicion que comprende metilfolato.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340759A1 (en) * 1988-05-06 1989-11-08 MAGIS FARMACEUTICI S.p.A. Salts of O-mono (di)-acetyl-glycero-mono-(bis)-(di)-phosphates of L-acetyl-carnitine and of L-acetyl carnitine esters
JP3942207B2 (ja) 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6066664A (en) * 1997-06-06 2000-05-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for decreasing the appetite in bulimic, overweight individuals

Also Published As

Publication number Publication date
ES2236910T3 (es) 2005-07-16
US6335021B1 (en) 2002-01-01
IT1291930B1 (it) 1999-01-21
KR20010013887A (ko) 2001-02-26
JP2002505681A (ja) 2002-02-19
PT1001760E (pt) 2005-04-29
ITRM970365A1 (it) 1998-12-18
EP1001760A1 (en) 2000-05-24
ATE288265T1 (de) 2005-02-15
DE69828881T2 (de) 2006-01-19
EP1001760B1 (en) 2005-02-02
ITRM970365A0 (da) 1997-06-18
WO1998057629A1 (en) 1998-12-23
DE69828881D1 (de) 2005-03-10
AU7930498A (en) 1999-01-04
CA2294589A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
DK1001760T3 (da) Præparat til behandling af sindslidelser hos sunde individer
DK1066036T3 (da) Midler med serotoninrelateret aktivitet til behandling af sövnapnö
DE60133389D1 (de) Gabapentinanaloga für schlafstörungen
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
DK1007040T3 (da) Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
PT1124556E (pt) Utilizacao de (r)-tofisopam opticamente puro para tratamento e prevencao de perturbacoes da ansiedade e sua composicao
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO990450L (no) Behandling av sinnslidelser
ID26132A (id) Pembuatan untuk pengobatan dari gangguan fungsi ereksi
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
NO20024331D0 (no) Behandling av lidelser relatert til det serotonerge system
ATE319677T1 (de) Cholinderivate zur behandlung der alzheimerkrankheit
NO984430L (no) Anvendelse av en inhibitor av Na+/H+-utveksler for fremstilling av medikament for behandling av profylakser av sykdommer i sentralnervesystemet
NO20005286D0 (no) Behandling av generelle angstforstyrrelser med paroxetine
KR970020846U (ko) 근골격계질환 치료보조용 반창고
DK82798A (da) Treatment of GABA-uptake related disorders
KR970036578U (ko) 침대차의 침대 발판 구조
DE69201975D1 (de) Pyrimido-benzothiazinderivate zur Behandlung von Entzündung, Allergie and kardiovaskulären Erkrankung.
DK0900078T3 (da) Anvendelse af benzonaphthalenderivater til fremstilling af lægemidler til behandling af sygdomme i nervesystemet
UA25585A (uk) Спосіб корекції гемодиhамічhих порушеhь у кардіохірургічhих хворих